Speakers

Suryanarayana Sastry Akella

Markets Lead Cognizant

Sastry manages multiple large pharma accounts for Cognizant and is responsible for service delivery. He also plays the lead for Cognizant’s managed markets practice, where he stewards business growth. With 20+ years of experience in Life Sciences and heath care, he brings a data centric approach to solution design and problem solving.

Brian McCartney

VP Strategic Innovation & Policy, McKesson

Brian has responsibility to proactively monitor drug pricing reform issues – including legislative, regulatory and administrative actions at the federal and state level – that could impact strategic and business outcomes for McKesson and their customers, partners and other industry stakeholders in the U.S. pharmaceutical value chain. In addition, Brian assesses financial implications for McKesson, and develops strategies and operational solutions to manage risk and drive business value, harnessing the breadth and depth of enterprise assets and capabilities. Brian has been with McKesson for a little over a year and has close to 20 years of pharmaceutical manufacturer experience in government pricing and policy at J&J, Endo Pharmaceuticals and most recently at AstraZeneca. Brian is a subject matter expert in government price reporting that gives him a deep understanding of the U.S. pharmaceutical supply chain, including 340B, buy and bill and diverse payer segments.

John Michael O’Brien, PharmD, MPH

President & CEO National Pharmaceutical Council

John M. O’Brien, PharmD, MPH, is the president and chief executive officer of the National Pharmaceutical Council (NPC), which sponsors and participates in research on the appropriate use of pharmaceuticals and the clinical and economic value of pharmaceutical innovation. Dr. O’Brien’s broad experience spans the private sector, academia and government. Prior to NPC, Dr. O’Brien was senior advisor to the U.S. Secretary of Health and Human Services and deputy assistant secretary of planning and evaluation (health policy). He also has held senior policy positions in the life sciences and managed care industries, including at CareFirst BlueCross BlueShield and the Centers for Medicare & Medicaid Services (CMS), and served as a health policy fellow in the U.S. Senate. Dr. O’Brien earned his doctorate in pharmacy at Nova Southeastern University and his master’s degree in public health at the Johns Hopkins Bloomberg School of Public Health.

Caitlyn Ozier

Counsel, King & Spalding

Caitlyn Ozier is an FDA & Life Sciences attorney at King & Spalding who regularly counsels pharmaceutical, biotech, and medical device companies on a range of regulatory and compliance matters that impact their sales, marketing, and pricing activities. She has specific expertise counseling life sciences companies on state drug price transparency, prescription drug affordability board, and price gouging laws.

Rehmann Rayani

Chief Strategy & Marketing Officer, Model N

Rehmann Rayani is Chief Strategy & Marketing Officer and joined Model N in 2018. Rehmann is responsible for leading Model N’s Corporate Strategy function as well as all aspects of the Marketing function across corporate & growth marketing, product marketing, and communications. Rehmann brings 18 years of experience in enterprise software and technology as a strategy and go-to-market leader. Prior to joining Model N, he spent over 4 years at Plex Systems in a variety of senior management roles including VP/GM of the Supply Chain Business Unit and VP of Corporate Strategy. Earlier in his career, Rehmann was a management consultant at Oliver Wyman and an investment associate at ValueAct Capital.

Rehmann holds an MBA from The Wharton School of the University of Pennsylvania and a degree in finance and physics from McGill University.

John Schiavone

Principal Solutions Consultant, Model N

John Schiavone is a Solution Engineer with 17 years of experience with Model N and over 25 years of experience in the Life Science industry providing technology solutions to business objectives. John has implemented Revenue Management projects for several of the top Pharmaceutical and Med Tech companies and he brings in depth knowledge of contracting, pricing, quoting, rebates, chargebacks, compliance, master data management as well as reporting and analytics. John is currently on the sales team to help customers with their challenges, find solutions to their problems and educate them on the value of Model N Revenue Execution, especially to the Med Tech community.

Kevin Suh

Director Global Commercial Operations, Qualcomm

Kevin Suh, Director of Global Commercial Operations at Qualcomm, is a seasoned professional with extensive expertise in the semiconductor industry including Xilinx, Micron, Samsung, and CSR. Specializing in global sales operations and pricing strategy and execution.

Vijay Vidiyala

VP Global Customer Success, Model N

Vijay leads Model N HT Professional Services and Channel Data Management operations team. I joined Model N 11 years back. For the initial 5 years I led Model N Europe customer success practice for both Life Sciences and High Tech Verticals. Before joining Model N, I worked at SAP for 10 years and led go-to-market activities for SAP SaaS Solutions.

Inchul Yoon

Solutions Architect Model N

Inchul Yoon is a Solutions Architect on the Life Sciences Professional Services team at Model N.  With over 11 years of experience at Model N, he has worked directly with top pharmaceutical manufacturers on project implementations of Model N suite products.  Inchul has particular expertise in Model N’s script scrubbing solution Validata and also has extensive experience in master data management, chargebacks, and managed care contracting and rebates.